Lenalidomide in the management of eosinophilic dermatosis of hematological malignancy
- PMID: 31144726
- DOI: 10.1111/1346-8138.14916
Lenalidomide in the management of eosinophilic dermatosis of hematological malignancy
Abstract
Eosinophilic dermatosis of hematological malignancy is a paraneoplastic skin eruption associated with chronic lymphocytic leukemia and other B-cell malignancies. It clinically resembles an insect bite reaction and it can precede the symptoms of the hematological malignancy or be related to a more aggressive course. Different treatments have been proposed, but partial response and recurrence are frequent. Herein, we describe a case of eosinophilic dermatosis associated with mantle cell lymphoma with remission after lenalidomide therapy.
Keywords: eosinophilic dermatosis of hematological malignancy; eosinophilic reactive dermatoses; hematological malignancies; lenalidomide; paraneoplastic disorders.
© 2019 Japanese Dermatological Association.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
